Statistics for FARMA-DERMA S.r.l.

30Total Devices

5Basic UDI-DIs

0Not destined for EU market

0Certificates

0Valid

0Expiring < 6 months

11Countries

Certificate health for FARMA-DERMA S.r.l.

No certificates registered for this manufacturer.

Showing 1–25 of 30 devices.

Trade name	Reference / catalog number	UDI-DI code	Quantity	Status
1046	`1046`	`08032595870074`	10	On the market
2030	`2030`	`08032595871699`	3	On the market
2001	`2001`	`08032595871248`	3	On the market
1001	`1001`	`08032595871231`	10	On the market
1015	`1015`	`08032595870272`	10	On the market
2048	`2048`	`08032595871880`	3	On the market
2004	`2004`	`08032595871323`	1	On the market
1004	`1004`	`08032595871316`	1	On the market
1005	`1005`	`08032595871330`	1	On the market
2005	`2005`	`08032595871347`	1	On the market
1002	`1002`	`08032595871255`	10	On the market
2002	`2002`	`08032595871262`	3	On the market
1038	`1038`	`08032595870166`	10	On the market
2024	`2024`	`08032595871514`	3	On the market
2009	`2009`	`08032595871477`	3	On the market
1010	`1010`	`08032595870814`	10	On the market
2050	`2050`	`08032595871934`	3	On the market
1071	`1071`	`08032595871927`	10	On the market
Cicatridine crème	`1021`	`08032595871637`	1	On the market
Cicatridine crème	`1022`	`08032595870722`	1	On the market
Cicatridine ovules vaginaux	`1008`	`08032595871453`	10	On the market
Cicatridine PLUS ovules vaginaux	`1078`	`08032595872054`	10	On the market
Cicatrine suppositoires	`1009`	`08032595871521`	10	On the market
1037	`1037`	`08032595870197`	10	On the market
2051	`2051`	`08032595871965`	3	On the market

Devices placed in 11 countries

EUDAMED update: Feb 14, 2024

IT-MF-000020737

Active

Name: Ministero della salute - Direzione generale dei dispositivi medici e del servizio farmaceutico
SRN: IT-CA-070
Phone: +39 06 5994 3199/ +39 06 5994 3207
Email: segr.dgfdm@sanita.it

MONTORSI Lorena
art. 15 (a) the conformity of the devices is appropriately checked, in accordance with the quality management system under which the devices are manufactured, before a device is released; (c) the post-market surveillance obligations are complied with in accordance with Article 10(10); (d) the reporting obligations referred to in Articles 87 to 91 are fulfilled;
Hidden
CORNIA Francesca
art. 15 (b) the technical documentation and the EU declaration of conformity are drawn up and kept up-to-date;
Hidden
BINO Alessia
art. 15 (e) in the case of investigational devices, the statement referred to in Section 4.1 of Chapter II of Annex XV is issued.
Hidden